Streetbeat News

Analyst Ratings

TGT

Big-money investors have shown a bearish stance on Target (NYSE:TGT), with options trades indicating a sentiment split of 27% bullish and 72% bearish. Benzinga's options scanner revealed 11 unusual options trades, with a price range target from $90 to $130 over the last 3 months. The largest trades included a bullish call with a strike price of $105 expiring on 11/24/23 and a bearish call with a strike price of $100 expiring on 01/19/24. Target is the sixth-largest U.S. retailer, operating over 1,900 stores with over $100 billion in sales. The stock price is currently up 0.34% at $130.38, with potential overbought signals from RSI indicators. Analysts have mixed ratings on TGT, with an average target price of $149 and varying recommendations from Buy to Market Perform.

Portfolio Pulse from Benzinga Insights

November 17, 2023 | 4:15 pm

UHS

JP Morgan analyst Calvin Sternick has maintained a Neutral rating on Universal Health Services (NYSE:UHS) and reduced the price target from $152 to $144.

Portfolio Pulse from Benzinga Newsdesk

November 17, 2023 | 4:14 pm

USPH

JP Morgan analyst Calvin Sternick has maintained an Overweight rating on US Physical Therapy (NYSE:USPH) but reduced the price target from $108 to $99.

Portfolio Pulse from Benzinga Newsdesk

November 17, 2023 | 4:12 pm

THC

JP Morgan analyst Calvin Sternick has maintained an Overweight rating on Tenet Healthcare (NYSE:THC) but has reduced the price target from $91 to $81.

Portfolio Pulse from Benzinga Newsdesk

November 17, 2023 | 4:11 pm

TDOC

JP Morgan analyst Lisa Gill has maintained a Neutral rating on Teladoc Health (NYSE:TDOC) but has reduced the price target from $33 to $19.

Portfolio Pulse from Benzinga Newsdesk

November 17, 2023 | 4:09 pm

VSEC

Benchmark analyst Josh Sullivan has reaffirmed a Buy rating on VSE Corporation (NASDAQ:VSEC) and increased the price target from $70 to $85.

Portfolio Pulse from Benzinga Newsdesk

November 17, 2023 | 4:08 pm

PRVA

JP Morgan analyst Lisa Gill has maintained an Overweight rating on Privia Health Group (NASDAQ:PRVA) but has reduced the price target from $43 to $38.

Portfolio Pulse from Benzinga Newsdesk

November 17, 2023 | 4:07 pm

OMI

JP Morgan analyst Lisa Gill has maintained an Underweight rating on Owens & Minor (NYSE:OMI) and reduced the price target from $21 to $19.

Portfolio Pulse from Benzinga Newsdesk

November 17, 2023 | 4:06 pm

LFST

JP Morgan analyst Lisa Gill has maintained a Neutral rating on LifeStance Health Group (LFST) but has reduced the price target from $10 to $8.

Portfolio Pulse from Benzinga Newsdesk

November 17, 2023 | 4:04 pm

GPS

ROST

TWST

Ross Stores, Inc. (NASDAQ:ROST) reported strong third-quarter earnings, beating estimates with $1.33 per share and revenue of $4.92 billion, leading to an 8.8% stock surge. The company also raised its FY23 EPS guidance. Other stocks like The Gap, Inc. (NYSE:GPS), Twist Bioscience Corporation (NASDAQ:TWST), and several others also moved higher on Friday after reporting positive financial results or receiving favorable analyst ratings.

Portfolio Pulse from Lisa Levin

November 17, 2023 | 4:02 pm